Detalhe da pesquisa
1.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300386
2.
Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID-19 prevention.
Br J Haematol
; 204(5): 1908-1912, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38327109
3.
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Hematol Oncol
; 42(1): e3241, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058031
4.
Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia.
Int J Mol Sci
; 24(19)2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833915
5.
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells.
Haematologica
; 107(2): 427-436, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33440919
6.
iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis.
Cytotherapy
; 24(5): 482-488, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35181242
7.
Time-dependent analysis of adoptive immunotherapy following sequential FLAMSA-reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk myeloid neoplasia.
Eur J Haematol
; 108(3): 244-263, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902880
8.
[Invariant natural killer T cells : Cellular immune regulators with cytotoxic potential]. / Invariante natürliche Killer-T-Zellen : Zelluläre Immunregulatoren mit zytotoxischem Potenzial.
Pathologe
; 41(Suppl 2): 134-137, 2020 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-33156364
9.
G-CSF administration prior to donor lymphocyte apheresis promotes anti-leukaemic effects in allogeneic HCT patients.
Br J Haematol
; 186(1): 60-71, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30916396
10.
B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma.
Br J Haematol
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782604
11.
Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.
Blood
; 129(23): 3121-3125, 2017 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28416503
12.
TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.
Blood
; 128(6): 866-71, 2016 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27365424
13.
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.
Ann Hematol
; 97(12): 2491-2500, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30066039
14.
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
Blood
; 125(22): 3491-500, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795920
15.
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
Blood
; 126(4): 546-57, 2015 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26063163
16.
MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.
Blood
; 126(14): 1683-94, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26311362
17.
Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation.
Clin Transplant
; 31(7)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470884
18.
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
J Immunol
; 195(1): 347-55, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25994967
19.
CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.
Blood
; 124(22): 3320-8, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293774
20.
Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.
Blood
; 124(11): 1832-42, 2014 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25030062